272 related articles for article (PubMed ID: 22985444)
1. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
Tack J; Corsetti M
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
[TBL] [Abstract][Full Text] [Related]
2. Prucalopride succinate for the treatment of constipation: an update.
Bassotti G; Gambaccini D; Bellini M
Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of prucalopride in adults and children with chronic constipation.
Diederen K; Mugie SM; Benninga MA
Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
[TBL] [Abstract][Full Text] [Related]
4. Oral prucalopride in children with functional constipation.
Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
[TBL] [Abstract][Full Text] [Related]
5. Use of prucalopride in adults with chronic idiopathic constipation.
Vijayvargiya P; Camilleri M
Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
[No Abstract] [Full Text] [Related]
6. Prucalopride: A Review in Chronic Idiopathic Constipation.
Garnock-Jones KP
Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].
Layer P; Dathe K; Dignass A; Faiss S; Galle P; Lerch MM; Malfertheiner P; Wehrmann T; Zeuzem S
Z Gastroenterol; 2011 Aug; 49(8):969-70. PubMed ID: 21796580
[No Abstract] [Full Text] [Related]
8. Prucalopride for the treatment of constipation: a view from 2015 and beyond.
Bassotti G; Usai Satta P; Bellini M
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):257-262. PubMed ID: 30791758
[TBL] [Abstract][Full Text] [Related]
9. Prucalopride: a new drug for the treatment of chronic constipation.
Tack J
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):337-43. PubMed ID: 19673621
[TBL] [Abstract][Full Text] [Related]
10. [Some practical questions on chronic stipsis treatment with prucalopride].
Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
[TBL] [Abstract][Full Text] [Related]
11. Prucalopride: a review of its use in the management of chronic constipation.
Keating GM
Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
[TBL] [Abstract][Full Text] [Related]
12. An overview of the efficacy and safety of prucalopride for the treatment of chronic idiopathic constipation.
Daniali M; Nikfar S; Abdollahi M
Expert Opin Pharmacother; 2019 Dec; 20(17):2073-2080. PubMed ID: 31557072
[No Abstract] [Full Text] [Related]
13. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
[TBL] [Abstract][Full Text] [Related]
14. Prucalopride. In chronic constipation: poorly documented risks.
Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L
Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673
[TBL] [Abstract][Full Text] [Related]
16. Neurological and psychiatric adverse events with prucalopride: case report and possible mechanisms.
Carnovale C; Pellegrino P; Perrone V; Antoniazzi S; Pozzi M; Nisic A; Clementi E; Radice S
J Clin Pharm Ther; 2013 Dec; 38(6):524-5. PubMed ID: 23889005
[TBL] [Abstract][Full Text] [Related]
17. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.
Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B
Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968
[TBL] [Abstract][Full Text] [Related]
18. Effect of prucalopride on symptoms of chronic constipation.
Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
[TBL] [Abstract][Full Text] [Related]
19. Prucalopride: For functional constipation only?
Bellini M; Gambaccini D; Bassotti G
Tech Coloproctol; 2016 Jul; 20(7):433-6. PubMed ID: 27174045
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.
Camilleri M; Piessevaux H; Yiannakou Y; Tack J; Kerstens R; Quigley EMM; Ke M; Da Silva S; Levine A
Dig Dis Sci; 2016 Aug; 61(8):2357-2372. PubMed ID: 27056037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]